Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma.
Mbah NE, Myers AL, Sajjakulnukit P, Chung C, Thompson JK, Hong HS, Giza H, Dang D, Nwosu ZC, Shan M, Sweha SR, Maydan DD, Chen B, Zhang L, Magnuson B, Zhu Z, Radyk M, Lavoie B, Yadav VN, Koo I, Patterson AD, Wahl DR, Franchi L, Agnihotri S, Koschmann CJ, Venneti S, Lyssiotis CA.
Mbah NE, et al. Among authors: dang d.
Nat Commun. 2024 Oct 17;15(1):8983. doi: 10.1038/s41467-024-52973-4.
Nat Commun. 2024.
PMID: 39419964
Free PMC article.